Literature DB >> 27113974

Accelerating advanced-materials commercialization.

Elicia Maine1, Purnesh Seegopaul2.   

Abstract

Year:  2016        PMID: 27113974     DOI: 10.1038/nmat4625

Source DB:  PubMed          Journal:  Nat Mater        ISSN: 1476-1122            Impact factor:   43.841


× No keyword cloud information.
  5 in total

1.  Risks in new drug development: approval success rates for investigational drugs.

Authors:  J A Dimasi
Journal:  Clin Pharmacol Ther       Date:  2001-05       Impact factor: 6.875

2.  The price of innovation: new estimates of drug development costs.

Authors:  Joseph A DiMasi; Ronald W Hansen; Henry G Grabowski
Journal:  J Health Econ       Date:  2003-03       Impact factor: 3.883

3.  From bench to business.

Authors:  Jonathan D Linton; Steven T Walsh
Journal:  Nat Mater       Date:  2003-05       Impact factor: 43.841

4.  The changing face of corporate venturing in biotechnology.

Authors:  Georg von Krogh; Boris Battistini; Fotini Pachidou; Pius Baschera
Journal:  Nat Biotechnol       Date:  2012-10       Impact factor: 54.908

Review 5.  Carbon nanotubes: present and future commercial applications.

Authors:  Michael F L De Volder; Sameh H Tawfick; Ray H Baughman; A John Hart
Journal:  Science       Date:  2013-02-01       Impact factor: 47.728

  5 in total
  2 in total

1.  Raising financing through strategic timing.

Authors:  Elicia Maine; V J Thomas
Journal:  Nat Nanotechnol       Date:  2017-02-07       Impact factor: 39.213

Review 2.  Medical Micro/Nanorobots in Precision Medicine.

Authors:  Fernando Soto; Jie Wang; Rajib Ahmed; Utkan Demirci
Journal:  Adv Sci (Weinh)       Date:  2020-10-04       Impact factor: 16.806

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.